Benzimidazole derivative and use thereof

Details for Australian Patent Application No. 2005214271 (hide)

International Classifications

Event Publications

28 September 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 08 Sep 2006

28 September 2006 PCT application entered the National Phase

PCT publication WO2005/080384 Priority application(s): WO2005/080384

24 February 2011 Application Accepted

Published as AU-B-2005214271

3 March 2011 Corrigenda

Applications Accepted - Name Index Under the name Takeda Pharmaceutical Company Limited, Application No. 2005214271 under INID (54) correct the title to read Benzimidazole derivative and use as A II receptor antagonist Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2005270687 Forensic Technology Wai, Inc. 2006340864 Shell Internationale Research Maatschappij B.V. 201

23 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.